https://www.selleckchem.com/products/au-15330.html
02). Excised tumors revealed that DFMO/probenecid treatment decreases polyamines putrescine and spermidine, reduces MYCN protein levels and dephosphorylates retinoblastoma (Rb) protein (p-Rb ), suggesting DFMO/probenecid-induced cell cycle arrest. Addition of probenecid as an adjuvant to DFMO therapy may be suitable to decrease overall dose and improve drug efficacy in vivo. Addition of probenecid as an adjuvant to DFMO therapy may be suitable to decrease overall dose and improve drug efficacy in vivo. In the context of the phase-down
Curtir
Comentario
Compartilhar
